NCT07061236

Brief Summary

Cancer treatment often requires chemotherapy, which can be administered through portable devices called elastomeric pumps. These pumps allow medications such as 5-fluorouracil (5-FU) to be delivered continuously over an extended period while patients remain at home rather than staying in the hospital. Although this treatment approach offers greater convenience and independence, patients may experience anxiety and uncertainty related to pump use, treatment side effects, and self-care responsibilities. This study aims to determine whether providing structured education about elastomeric pump use and 5-FU treatment can improve patients' comfort and reduce anxiety. Participants receiving 5-FU chemotherapy through an elastomeric pump will be assigned to either an education group or a standard care group. Patients in the education group will receive additional training from the researcher using educational materials and a patient information booklet. The training will include information about safe pump use, management of treatment-related symptoms, precautions to take during treatment, and what to do if problems occur. Patients in the standard care group will continue to receive the routine information and care normally provided by the oncology clinic. Participants will complete questionnaires that measure comfort and anxiety before the study begins and again one month later. The results will help determine whether structured patient education improves the experience of individuals receiving outpatient chemotherapy through elastomeric pumps. The findings may help healthcare professionals develop more effective educational programs and supportive care strategies for patients receiving home-based chemotherapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Jul 2025

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2025

Completed
6 days until next milestone

Study Start

First participant enrolled

July 8, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 11, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 11, 2025

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 8, 2025

Completed
Last Updated

June 15, 2026

Status Verified

November 1, 2025

Enrollment Period

1 month

First QC Date

July 2, 2025

Last Update Submit

June 11, 2026

Conditions

Keywords

AnxietyCancerChemotherapyNursesPort Catheters

Outcome Measures

Primary Outcomes (1)

  • Anxiety (Beck Anxiety Inventory Score)

    Change in anxiety level from baseline to one month post-intervention, measured using the Beck Anxiety Inventory. The Beck Anxiety Inventory is a 21-item self-report scale with scores ranging from 0 to 63. Higher scores indicate greater anxiety severity and therefore a worse outcome. Scores of 0-7 indicate minimal anxiety, 8-15 mild anxiety, 16-25 moderate anxiety, and 26-63 severe anxiety.

    1 month

Secondary Outcomes (1)

  • Comfort (General Comfort Questionnaire-Short Form Score)

    1 month

Study Arms (2)

5-FU Elastomeric Pump Education Program

EXPERIMENTAL

Patients will receive face-to-face training on the use of the elastomeric pump with 5-FU, supported by an educational booklet.

Other: Elastomeric Pump Education

Standard Oncology Education and Care

NO INTERVENTION

Patients will receive standard institutional care without any additional education or training.

Interventions

This intervention involves a 15-20 minute face-to-face training session about the use of the elastomeric pump with 5-FU, supported by visual materials and an educational booklet developed by the researchers based on current literature and expert opinion

5-FU Elastomeric Pump Education Program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with cancer,
  • Able to understand Turkish and literate,
  • Medically fit to participate in the study,
  • Willing to participate in the study,
  • Aged 18 years or older.

You may not qualify if:

  • Diagnosed with a psychiatric disorder,
  • Unable to communicate effectively,
  • Refusing to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Biruni University

Istanbul, Zeytinburnu, 34015, Turkey (Türkiye)

Location

Koç University Hospital

Istanbul, Turkey (Türkiye)

Location

Related Publications (29)

  • Yilmaz SG, Arslan S. Effects of progressive relaxation exercises on anxiety and comfort of Turkish breast cancer patients receiving chemotherapy. Asian Pac J Cancer Prev. 2015;16(1):217-20. doi: 10.7314/apjcp.2015.16.1.217.

  • Uslu, Y., Olgun, N., Karanlık, H., User, İ. (2019). Port kateter uygulamaları: kanserli hastaların deneyimlerine ilişkin niteliksel bir çalışma. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, 10(3), 464-472.

    RESULT
  • Ulusoy, M., Şahin, N., Erkmen, H. (1998). Turkish version of The Beck Anxiety Inventory: Psychometric properties. Journal of Cognitive Psychother, 12, 28-35.

    RESULT
  • Temiz G, Durna Z. Evaluation of Quality of Life and Health Care Needs in Cancer Patients Receiving Chemotherapy. J Cancer Educ. 2020 Aug;35(4):796-807. doi: 10.1007/s13187-019-01533-2.

  • Shoemaker LK, Arora U, Rocha Lima CM. 5-fluorouracil-induced coronary vasospasm. Cancer Control. 2004 Jan-Feb;11(1):46-9. doi: 10.1177/107327480401100207.

  • Stewart T, Pavlakis N, Ward M. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina. Intern Med J. 2010 Apr;40(4):303-7. doi: 10.1111/j.1445-5994.2009.02144.x.

  • Sayin Y, Aksoy G. The effect of analgesic education on pain in patients undergoing breast surgery: within 24 hours after the operation. J Clin Nurs. 2012 May;21(9-10):1244-53. doi: 10.1111/j.1365-2702.2011.04009.x. Epub 2012 Mar 8.

  • Pu YL, Li ZS, Zhi XX, Shi YA, Meng AF, Cheng F, Ali A, Li C, Fang H, Wang C. Complications and Costs of Peripherally Inserted Central Venous Catheters Compared With Implantable Port Catheters for Cancer Patients: A Meta-analysis. Cancer Nurs. 2020 Nov/Dec;43(6):455-467. doi: 10.1097/NCC.0000000000000742.

  • Pinelli F, Cecero E, Degl'Innocenti D, Selmi V, Giua R, Villa G, Chelazzi C, Romagnoli S, Pittiruti M. Infection of totally implantable venous access devices: A review of the literature. J Vasc Access. 2018 May;19(3):230-242. doi: 10.1177/1129729818758999. Epub 2018 Mar 7.

  • Paleczny J, Banys-Jafernik B, Gazurek K, Kierpiec K, Szczerba H, Zipser P. Long-term totally implantable venous access port systems--one center experience. Anaesthesiol Intensive Ther. 2013 Oct-Dec;45(4):215-22. doi: 10.5603/AIT.2013.0042.

  • Paiva BS, de Carvalho AL, Kolcaba K, Paiva CE. Validation of the Holistic Comfort Questionnaire-caregiver in Portuguese-Brazil in a cohort of informal caregivers of palliative care cancer patients. Support Care Cancer. 2015 Feb;23(2):343-51. doi: 10.1007/s00520-014-2370-5. Epub 2014 Aug 2.

  • Öztaş, M., Alkan, İ., Öztaş, B. (2022). Determination of nursing practices regarding port catheter care. J Med Palliat Care, 3(1), 33-38.

    RESULT
  • Ozden D, Caliskan N. Turkish nurses' level of knowledge regarding implantable port catheter care. Jpn J Nurs Sci. 2012 Jun;9(1):1-8. doi: 10.1111/j.1742-7924.2011.00177.x. Epub 2011 Mar 14.

  • Önder, H., Tekbaş, G., Turmak, M., İnal, A., Ekici, F., Gümüş, H, Önder, A. (2014). Image-guided subcutaneous port implantation in patients with malignant diseases. European Journal of General Medicine, 1, 1-6.

    RESULT
  • Odabas H, Ozdemir NY, Ziraman I, Aksoy S, Abali H, Oksuzoglu B, Isik M, Civelek B, Dede D, Zengin N. Effect of port-care frequency on venous port catheter-related complications in cancer patients. Int J Clin Oncol. 2014 Aug;19(4):761-6. doi: 10.1007/s10147-013-0609-7. Epub 2013 Aug 27.

  • McCarthy M, Glick R, Green J, Plummer K, Peters K, Johnsey L, Deluca C. Comfort First: an evaluation of a procedural pain management programme for children with cancer. Psychooncology. 2013 Apr;22(4):775-82. doi: 10.1002/pon.3061. Epub 2012 Mar 13.

  • Kolcaba K, Schirm V, Steiner R. Effects of hand massage on comfort of nursing home residents. Geriatr Nurs. 2006 Mar-Apr;27(2):85-91. doi: 10.1016/j.gerinurse.2006.02.006.

  • Kim KS, Kwon SH. Comfort and quality of life of cancer patients. Asian Nurs Res (Korean Soc Nurs Sci). 2007 Sep;1(2):125-35. doi: 10.1016/S1976-1317(08)60015-8. Epub 2008 Dec 9.

  • Kia A, Waterson J, Bargary N, Rolt S, Burke K, Robertson J, Garcia S, Benavoli A, Bergstrom D. Determinants of Intravenous Infusion Longevity and Infusion Failure via a Nonlinear Model Analysis of Smart Pump Event Logs: Retrospective Study. JMIR AI. 2023 Sep 13;2:e48628. doi: 10.2196/48628.

  • Kesici, S., Tuna, V., Özkan, S., Cengiz, E., Türkmen, A. (2017). Venöz port kateter implantasyonu uygulanan hastaların retrospektif analizi. Cukurova Medical Journal, 42, 604-605.

    RESULT
  • Kaykunoğlu, M., Tambağ, H. (2022). Ayaktan Kemoterapi Alan Hastaların Sosyal Destek ve Anksiyete Düzeylerinin Belirlenmesi. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 9(3), 429-435.

    RESULT
  • Hou YF, Zhao AP, Feng YX, Cui XN, Wang LL, Wang LX. Nurses' knowledge and attitudes on comfort nursing care for hospitalized patients. Int J Nurs Pract. 2014 Dec;20(6):573-8. doi: 10.1111/ijn.12200. Epub 2013 Oct 11.

  • Esfahani H, Ghorbanpor M, Tanasan A. Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study. Iran J Ped Hematol Oncol. 2016;6(1):1-8. Epub 2016 Mar 15.

  • Çıtlık, S.C., Çevik, S., Özden, G. (2018). Genel Konfor Ölçeği Kısa Formunun Türkçe geçerlik ve güvenirlik çalışması. Diyabet, Obezite ve Hipertansiyonda Hemşirelik Forumu, 10(2), 16-22.

    RESULT
  • Chefchaouni AC, Ouedraogo JM, Bechar H, Belahcen MJ, Rahali Y. Retrospective analysis of failures of ambulatory elastomeric pumps containing 5-FU in a hospital pharmacy unit. J Oncol Pharm Pract. 2023 Jan;29(1):125-129. doi: 10.1177/10781552211060290. Epub 2021 Nov 16.

  • Can, A., Hintistan, S. (2021). Kemoterapi alan kanser hastalarının konfor düzeylerinin değerlendirilmesi. Bezmialem Science, 9(3), 310-316.

    RESULT
  • Burucu R, Turkben Polat H. Spiritual Well-Being Levels and Self-Care Agency of Patients Receiving Chemotherapy With Port Catheter: A Correlational, Descriptive Study. Holist Nurs Pract. 2024 Nov-Dec 01;38(6):331-340. doi: 10.1097/HNP.0000000000000655. Epub 2024 Oct 14.

  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available.

  • Abe T, Matsuzaka K, Nakayama T, Otsuka M, Sagara A, Sato F, Yumoto T. Impact of air temperature and drug concentration on liquid emission from elastomeric pumps. J Pharm Health Care Sci. 2021 Jan 5;7(1):1. doi: 10.1186/s40780-020-00185-5.

MeSH Terms

Conditions

Anxiety DisordersNeoplasms

Condition Hierarchy (Ancestors)

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
No masking was performed due to the nature of the educational intervention.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to intervention or control group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assist. Prof.

Study Record Dates

First Submitted

July 2, 2025

First Posted

July 11, 2025

Study Start

July 8, 2025

Primary Completion

August 11, 2025

Study Completion

September 8, 2025

Last Updated

June 15, 2026

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Data will only be shared upon reasonable request and subject to approval by the ethics committee.

Locations